1. Home
  2. KALA vs CENN Comparison

KALA vs CENN Comparison

Compare KALA & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • CENN
  • Stock Information
  • Founded
  • KALA 2009
  • CENN 2013
  • Country
  • KALA United States
  • CENN United States
  • Employees
  • KALA N/A
  • CENN N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • CENN Auto Manufacturing
  • Sector
  • KALA Health Care
  • CENN Consumer Discretionary
  • Exchange
  • KALA Nasdaq
  • CENN Nasdaq
  • Market Cap
  • KALA 26.2M
  • CENN 30.4M
  • IPO Year
  • KALA 2017
  • CENN N/A
  • Fundamental
  • Price
  • KALA $5.48
  • CENN $0.62
  • Analyst Decision
  • KALA Strong Buy
  • CENN
  • Analyst Count
  • KALA 3
  • CENN 0
  • Target Price
  • KALA $14.00
  • CENN N/A
  • AVG Volume (30 Days)
  • KALA 125.5K
  • CENN 532.2K
  • Earning Date
  • KALA 08-05-2025
  • CENN 08-12-2025
  • Dividend Yield
  • KALA N/A
  • CENN N/A
  • EPS Growth
  • KALA N/A
  • CENN N/A
  • EPS
  • KALA N/A
  • CENN N/A
  • Revenue
  • KALA N/A
  • CENN $31,097,533.00
  • Revenue This Year
  • KALA N/A
  • CENN N/A
  • Revenue Next Year
  • KALA N/A
  • CENN N/A
  • P/E Ratio
  • KALA N/A
  • CENN N/A
  • Revenue Growth
  • KALA N/A
  • CENN 234.45
  • 52 Week Low
  • KALA $2.92
  • CENN $0.61
  • 52 Week High
  • KALA $11.20
  • CENN $1.83
  • Technical
  • Relative Strength Index (RSI)
  • KALA 55.78
  • CENN 37.66
  • Support Level
  • KALA $4.36
  • CENN $0.65
  • Resistance Level
  • KALA $7.00
  • CENN $0.76
  • Average True Range (ATR)
  • KALA 0.75
  • CENN 0.07
  • MACD
  • KALA 0.07
  • CENN -0.01
  • Stochastic Oscillator
  • KALA 49.17
  • CENN 1.82

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

Share on Social Networks: